97 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 34075552 | Sacubitril/Valsartan Decreases Atrial Fibrillation Susceptibility by Inhibiting Angiotensin II-Induced Atrial Fibrosis Through p-Smad2/3, p-JNK, and p-p38 Signaling Pathways. | 2022 Feb | 3 |
2 | 33779339 | Time-Dependent Effects of Individual and Combined Treatments With Nebivolol, Lisinopril, and Valsartan on Blood Pressure and Vascular Reactivity to Angiotensin II and Norepinephrine. | 2021 Sep | 2 |
3 | 34400686 | Cardioprotective effects of early intervention with sacubitril/valsartan on pressure overloaded rat hearts. | 2021 Aug 16 | 2 |
4 | 34431038 | Blocking angiotensin 2 receptor attenuates diabetic nephropathy via mitigating ANGPTL2/TL4/NF-κB expression. | 2021 Sep | 2 |
5 | 32466632 | Regulation of epithelial mesenchymal transition by the renin-angiotensin system: a role for klotho in renal tubular epithelial cells. | 2020 Jan-Feb | 1 |
6 | 33425219 | AT1R/GSK-3β/mTOR Signaling Pathway Involved in Angiotensin II-Induced Neuronal Apoptosis after HIE Both In Vitro and In Vivo. | 2020 | 2 |
7 | 31030610 | Strong and Sustained Antihypertensive Effect of Small Interfering RNA Targeting Liver Angiotensinogen. | 2019 Jun | 1 |
8 | 31803758 | Activation of the Human Angiotensin-(1-12)-Chymase Pathway in Rats With Human Angiotensinogen Gene Transcripts. | 2019 | 1 |
9 | 29620193 | Influence of the interaction between Ac‑SDKP and Ang II on the pathogenesis and development of silicotic fibrosis. | 2018 Jun | 2 |
10 | 29981238 | Angiotensin II, a stress-related neuropeptide in the CNS, facilitates micturition reflex in rats. | 2018 Sep | 1 |
11 | 26728369 | [Valsartan inhibits angiotensin II-Notch signaling of mesangial cells induced by high glucose]. | 2016 Jan | 2 |
12 | 27050934 | Valsartan attenuates intimal hyperplasia in balloon-injured rat aortic arteries through modulating the angiotensin-converting enzyme 2-angiotensin-(1-7)-Mas receptor axis. | 2016 May 15 | 2 |
13 | 25362207 | Angiotensin receptor neprilysin inhibitor LCZ696 attenuates cardiac remodeling and dysfunction after myocardial infarction by reducing cardiac fibrosis and hypertrophy. | 2015 Jan | 1 |
14 | 25460028 | Effects and underlying mechanisms of human opiorphin on cardiovascular activity in anesthetized rats. | 2015 Feb 15 | 1 |
15 | 25823960 | Novel mechanism of cardiac protection by valsartan: synergetic roles of TGF-β1 and HIF-1α in Ang II-mediated fibrosis after myocardial infarction. | 2015 Aug | 3 |
16 | 26195268 | Angiotensin type 1 receptor mediates renal production and conversion of prostaglandins E2 to F2α in conscious diabetic rats. | 2015 Dec | 1 |
17 | 26202363 | Valsartan Reduced Atrial Fibrillation Susceptibility by Inhibiting Atrial Parasympathetic Remodeling through MAPKs/Neurturin Pathway. | 2015 | 1 |
18 | 26330760 | Trichostatin A Modulates Angiotensin II-induced Vasoconstriction and Blood Pressure Via Inhibition of p66shc Activation. | 2015 Sep | 2 |
19 | 24420538 | Aliskiren reduces myocardial ischemia-reperfusion injury by a bradykinin B2 receptor- and angiotensin AT2 receptor-mediated mechanism. | 2014 Apr | 3 |
20 | 24445059 | Angiotensin II induces Fat1 expression/activation and vascular smooth muscle cell migration via Nox1-dependent reactive oxygen species generation. | 2014 Jan | 3 |
21 | 24486428 | Opiorphin increases blood pressure of conscious rats through renin-angiotensin system (RAS). | 2014 May | 1 |
22 | 25014676 | Valsartan decreases neointimal hyperplasia in balloon-injured rat aortic arteries by upregulating HO-1 and inhibiting angiotensin II type 1 receptor. | 2014 Aug 21 | 1 |
23 | 25431019 | Angiotensin II acting on brain AT1 receptors induces adrenaline secretion and pressor responses in the rat. | 2014 Nov 28 | 1 |
24 | 23190689 | Powerful vascular protection by combining cilnidipine with valsartan in stroke-prone, spontaneously hypertensive rats. | 2013 Apr | 2 |
25 | 23288202 | Downregulation of the cardiotrophin-1 gene expression by valsartan and spironolactone in hypertrophied heart rats in vivo and rat cardiomyocyte H9c2 cell line in vitro: a novel mechanism of cardioprotection. | 2013 Apr | 1 |
26 | 22222314 | Restoration of the blood pressure circadian rhythm by direct renin inhibition and blockade of angiotensin II receptors in mRen2.Lewis hypertensive rats. | 2012 Feb | 3 |
27 | 22792802 | [Effect of Astragali Radix injection on myocardial cell mitochondrial structure and function in process of reversing myocardial cell hypertrophy]. | 2012 Apr | 2 |
28 | 23141017 | [Effects of valsartan on aortic angiotensin converting enzyme 2 expression after aortic balloon injury in rats]. | 2012 Aug | 1 |
29 | 21293118 | Effects of an N-type calcium antagonist on angiotensin II-renin feedback. | 2011 | 3 |
30 | 21355302 | [Protective effect of valsartan or/and ligustrazine on hippocampal neuronal loss in rats with vascular dementia]. | 2011 Jan | 1 |
31 | 21418803 | [Effect of valsartan on vasoconstriction induced by the chronic injury of the adventitia in the rat collared carotid artery]. | 2011 Jan | 3 |
32 | 19769609 | (Pro)renin receptor contributes to diabetic nephropathy by enhancing renal inflammation. | 2010 Mar | 1 |
33 | 20175999 | Effect of angiotensin II on the WNK-OSR1/SPAK-NCC phosphorylation cascade in cultured mpkDCT cells and in vivo mouse kidney. | 2010 Mar 19 | 2 |
34 | 20571281 | Role of Fosinopril and Valsartan on Klotho Gene Expression Induced by Angiotensin II in Rat Renal Tubular Epithelial Cells. | 2010 | 5 |
35 | 19145780 | p38 MAPK contributes to angiotensin II-induced COX-2 expression in aortic fibroblasts from normotensive and hypertensive rats. | 2009 Jan | 3 |
36 | 19246637 | Angiotensin II induces renal plasminogen activator inhibitor-1 and cyclooxygenase-2 expression post-transcriptionally via activation of the mRNA-stabilizing factor human-antigen R. | 2009 Apr | 2 |
37 | 19662023 | Significance of angiotensin II receptor blockers with high affinity to angiotensin II type 1 receptors for vascular protection in rats. | 2009 Oct | 1 |
38 | 17965735 | Effects of angiotensin II blockade on inflammation-induced alterations of pharmacokinetics and pharmacodynamics of calcium channel blockers. | 2008 Jan | 1 |
39 | 18023891 | An angiotensin II receptor antagonist reduces inflammatory parameters in two models of colitis. | 2008 Feb 7 | 2 |
40 | 18406589 | Effect of total flavonoid fraction of Astragalus complanatus R. Brown on angiotensin II-induced portal-vein contraction in hypertensive rats. | 2008 Sep | 1 |
41 | 18560380 | Angiotensin II promotes NO production, inhibits apoptosis and enhances adhesion potential of bone marrow-derived endothelial progenitor cells. | 2008 Jul | 1 |
42 | 18566342 | Redox-sensitive signaling by angiotensin II involves oxidative inactivation and blunted phosphorylation of protein tyrosine phosphatase SHP-2 in vascular smooth muscle cells from SHR. | 2008 Jul 18 | 1 |
43 | 18619357 | [Changes of c-fos, c-jun mRNA expressions in cardiomyocyte hypertrophy induced by angiotensin II and effects of tanshinone II A]. | 2008 Apr | 1 |
44 | 18846332 | Changes of c-fos and c-jun mRNA expression in angiotensin II-induced cardiomyocyte hypertrophy and effects of sodium tanshinone IIA sulfonate. | 2008 Oct | 2 |
45 | 18853116 | Effect of sodium tanshinone II A sulfonate on cardiac myocyte hypertrophy and its underlying mechanism. | 2008 Sep | 1 |
46 | 19020766 | Inhibition of experimental abdominal aortic aneurysm in a rat model by the angiotensin receptor blocker valsartan. | 2008 Dec | 2 |
47 | 19080339 | Effect of valsartan on the expression of angiotensin II receptors in the lung of chronic antigen exposure rats. | 2008 Nov 20 | 1 |
48 | 17068200 | Angiotensin II-induced neural differentiation via angiotensin II type 2 (AT2) receptor-MMS2 cascade involving interaction between AT2 receptor-interacting protein and Src homology 2 domain-containing protein-tyrosine phosphatase 1. | 2007 Feb | 1 |
49 | 17211247 | Pressor response induced by central angiotensin II is mediated by activation of Rho/Rho-kinase pathway via AT1 receptors. | 2007 Feb | 1 |
50 | 17533199 | NADPH oxidase contributes to vascular inflammation, insulin resistance, and remodeling in the transgenic (mRen2) rat. | 2007 Aug | 1 |